Why is Mold-Tek Packaging share price rising in bear-hit market? EXPLAINED
Monday's fall on the Indian stock market marked the third consecutive day on which the benchmark indices closed in the red zone over a delayed India-US trade deal ahead of the US President Donald Trump's 1 August 2025 tariff deadline, relentless foreign capital outflows, and muted Q1 results, which continue to dampen investor risk appetite.
The packaging firm's net profits rose 35.5% to ₹ 22.39 crore in the first quarter of the financial year 2025-26, compared on a year-on-year (YoY) basis with ₹ 16.52 crore in the same quarter of the previous fiscal year, as per the company's statements.
Mold-Tek Packaging's revenue from core operations jumped 22% to ₹ 240.55 crore in the first quarter of the current fiscal year, compared YoY with ₹ 196.72 crore in the same period a year ago.
Mold-Tek Packaging's share price jumped 2.30% to ₹ 757.30 during Monday's stock market session, compared to ₹ 740.35 in the previous market close. The company announced its first-quarter results during the stock market session on 28 July 2025.
Shares of the packaging company have given stock market investors more than 233% returns in the last five years. However, in the last one-year period, the stock has lost 5.41%.
On a year-to-date (YTD) basis, the shares have gained 14.06% and are currently trading 3.20% higher in the last five market sessions on the Indian stock market.
Mold-Tek Packaging stock hit its 52-week high level at ₹ 841.80 on 1 August 2024, while the 52-week low level was at ₹ 415 on 7 April 2025, according to the BSE data. The company's market capitalisation stood at ₹ 2,513.27 crore as of the stock market session on Monday, 28 July 2025.
Read all stories by Anubhav Mukherjee
Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
17 minutes ago
- Hans India
Advanced ortho implant manufacturing facility to be housed in AMTZ
Visakhapatnam: Ina landmark collaboration that spans three continents, OIC International (USA), Medi Mold, part of the Andhra Pradesh Medtech Zone (AMTZ) (India), and AddUp, a subsidiary of Fives Group (France) announced a strategic partnership to establish India's most advanced orthopaedic implant manufacturing facility. This trilateral arrangement marks a decisive step towards transforming India into a global hub for high-performance orthopaedic implants while aligning with the Indian government's 'Make in India' and medical self-reliance initiatives. Powered by 3D-printing and precision engineering, the facility will be housed in AMTZ, India's flagship medical device manufacturing park. OIC is launching the first-of-its-kind line of implants manufactured in India using advanced additive 3D technology designed for both domestic and global markets. Developed with proprietary technology, these implants aim to significantly reduce post-surgery recovery time while delivering cutting-edge solutions at a fraction of the cost and can be produced on a mass scale, close to the delivery points. 'This partnership reflects our commitment to making world-class orthopaedic implants affordable and accessible in India,' said Shetty, CEO of OIC International. Further, the CEO stated that India is a key strategic market, and 3D printing is the platform that enables them to innovate, lower costs, and meet the country's growing surgical needs. 'By manufacturing locally at AMTZ, we align with the government of India's Make in India vision delivering global-quality care to Indian patients,' he emphasised. At the core of the initiative is AddUp's cutting-edge metal additive manufacturing technology, which will serve as the backbone of the new facility. By enabling the production of geometrically complex, patient-specific implants with reduced material waste, 3D printing introduces a paradigm shift in how orthopaedic devices are designed, validated, and brought to market. The first metal 3D printer from AddUp's FormUp range will be installed at AMTZ, enabling rapid prototyping and market entry. This infrastructure, operated by Medi Mold, will ensure speed, flexibility, and efficiency in manufacturing, a vital combination for meeting the growing orthopaedic demand in India and abroad. 'Orthopaedic implants have traditionally been a business of machining. For the first time, 3D printing and modern manufacturing techniques are coming to play a role in modern implants. AMTZ and its scientific facilities, quality control systems and supporting infrastructure such as Gamma Sterilisation is the right place for 3D printed implant production in India. We look forward to making this a global supply chain benefiting patients with high quality implants,' underlined Jitendra Sharma, MD and CEO of AMTZ. Partnership of Medi Mold, Fives and OIC with AMTZ will create a global centre for 3D printed implants in India. Supporting innovation, equity, and market access through this partnership, the collaboration aims to address three fundamental challenges in orthopaedics. They include technology-led innovation, affordability and market access. The new facility will offer an integrated manufacturing platform for low-cost implants for public sector procurement, supporting government hospitals and healthcare schemes. Meanwhile, OIC will have the ability to support India's fast-growing private healthcare market. 'By joining forces with OIC International and Medi Mold, we're accelerating access to innovative, high-performance medical solutions through additive manufacturing,' said Julian Marcilly, president of AddUp.' The collaboration marks a strategic milestone for AddUp, enabling it to bring industrial metal 3D printing expertise to the Indian market and support the production of next-generation orthopaedic implants. Emphasising on the partnership built on shared vision, executive director at Wodehouse Capital Advisors, Mumbai, Sraboni Haralalka, said, 'We are proud to have been entrusted with the India Entry mandate by OIC International. This collaboration brings together leading innovators to disrupt the orthopaedic implant market in India by delivering cutting-edge technology at accessible prices.' Wodehouse Capital also noted significant investor interest, from both financial and strategic players, looking to tap into India's rapidly growing medical devices sector.
Hans India
17 minutes ago
- Hans India
Def tech co takes ‘Make in India, Make for the World' to Philippines
Bengaluru: In a move that reinforces Prime Minister Narendra Modi's vision of 'Make in India, Make for the World', and India's growing role as a global defence manufacturing hub, SMPP Limited, a leading Indian defence technology company, has signed a landmark Memorandum of Understanding (MoU) with Asia Defence and Firepower Corporation (ADFC) of the Philippines to establish a strategic joint venture corporation (JVC). The proposed JVC will be headquartered in the Philippines and focus on manufacturing, assembling, and distributing a range of SMPP's advanced defence products, tailored to support the Philippine government's Self-Reliant Defence Posture (SRDP) initiative under Republic Act No. 12024.
New Indian Express
17 minutes ago
- New Indian Express
US tariffs will hit Kerala's exports sector hard: Finance Minister Balagopal
THIRUVANANTHAPURAM: The US decision to impose a 50% tariff on Indian goods will have a serious impact on Kerala's economy as the state makes large-scale exports to the US, Finance Minister K N Balagopal has said. It is a bullying tactic to control the country's market, he said. 'Our exports to the US include shrimp and other fish produce, textiles, spices, cashew, coir, etc. Medical equipment too is exported in large quantities. Besides, there is modest export of semiconductors and chips. Software exports too will be affected,' he told reporters on Friday. 'The Prime Minister has said that strict measures would be taken in the wake of the US move. It is time for all to stand united and safeguard the country's interests,' he said. He urged the Union government to convene a meeting of all states to formulate strategies to protect the country's trade and economy. Calling the prohibitive tariff a ploy of the US to control the Indian market, he said,'They will ask India to rationalise our tax regime so that it can dump products in our market,' he said. The minister also said the tariff will have an impact on the labourers' wages and farmers' income. Companies will be forced to reduce wages and farmers will be forced to sell their produce at low rates. Balagopal criticised the Centre for its recent Bilateral Free Trade Agreement with the UK. Under this, import duty on luxury cars and liquor was reduced drastically.
